Boehringer Ingelheim case study
This Merative landing page states only that Boehringer Ingelheim used MarketScan's diverse, longitudinal real-world data to advance its research, categorized under "Real-world Evidence," "Life Sciences," and "Longitudinal data." It contains no specific numbers, methods detail, or outcomes on the page itself; the full case study is only available as a downloadable PDF that was not reachable via fetch.
Merative is the former IBM Watson Health, now an independent company behind the MarketScan claims database and the Zelta clinical-trial platform.
This sits in the Data Providers stage of the AI use-case lifecycle: Named examples from the real-world-data, claims and competitive-intelligence providers pharma AI systems are trained on, benchmarked against, or run inside of.
Published by Merative on its own site — read the original case study on merative.com ↗
Note: Landing page only; substantive detail is gated in a downloadable PDF not reachable via WebFetch.
Related use cases
- 01Thought Leadership - MarketScan
- 02How one Canadian research center increased their sample size and strengthened insights
- 03Examining Variations in Elective Surgery Prices Across the U.S.
- 04Getting ahead of drug supply challenges
- 05Veristat Case Study
- 06served its expanding clientele with a modular clinical development solution